Page results
-
UCLH is one of the largest blood cancers treatment centres in Europe, with both inpatient beds and a comprehensive day care service. The service is the main treatment centre for patients from north and east London, and west Essex.
-
Today we are launching the new UCLH strategy for 2023-2027. Developed with staff, patients and key partners, the strategy sets the future direction of UCLH over the next five years.
-
This leaflet explains the support a transition coordinator at the Adolescent Rheumatology Department provides, and how they can help.
-
Tasnim tells us about her experience training with the Pharmacy team at UCLH and how their support has encouraged her to pursue this career.
-
Emma, our support and information specialist, gives tips to overcome loneliness.
-
Information for patients and visitors on patient isolation.
-
This information is for patients who have attended the emergency department with an undisplaced or minimally displaced fracture (broken bone) at the base of your 5th metatarsal.
-
This information is for patients, (and their family and carers), who are considering having Uterine Artery (Fibroid) Embolisation (UAE). It explains what is involved and the possible risks.
-
The Maternal Medicine team provides care for women with pre-existing medical disorders or pregnancy-related medical conditions. We work in a multidisciplinary team of doctors and midwives in order to provide the best standard of care for women and their babies.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
File results
-
FOI/2024/0401 - Hospital treatments for abortion complications
-
FOI/2024/0402 - Various IT systems used at the Trust
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0512 - Patient harm and the cost 2020-2023
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0412 - Healthcare travel costs scheme for patients